My Watchlist for Monday, October 10
( click to enlarge )
IntelliPharmaCeutics Intl Inc (NASDAQ:IPCI) The company on Friday received tentative approval from the U.S. FDA for the Company's abbreviated new drug application for quetiapine fumarate extended-release tablets in the 50, 150, 200, 300 and 400 mg strengths. This press release was announced after the markets closed. In after-hours trading, the stock closed with a gain of 50% at 3.57. It will be interesting to see pre market on Monday how it starts out. On the long-time frame above, you can see the pivot resistance points. I mentioned several times on twitter that IntelliPharmaCeutic was looking constructive from a technical standpoint, with the A/D indicator (accumulation/distribution line) showing clear signs of accumulation. A huge congratulation’s to you, if you paid attention to my alerts on IPCI, as you are probably sitting on same pretty hefty gains at the moment. I will use the pivot resistance points and the price targets of analysts to determine my exit strategy. To receive my alerts before the crowd follow me on twitter.
( click to enlarge )
Tokai Pharmaceuticals Inc (NASDAQ:TKAI) is another stock I have mentioned a few times in the past few weeks showing steady accumulation on charts. I believe things will heat up this month and have based my bullish position on the following factors:
- My system detected unusual call buying in the Oct/Nov 5 and 7.5 calls respectively last month
- Steady accumulation on charts - All short-term EMAs are now rising.
- The company is trading below cash per share.
- It recently broke a bullish flag higher, so a new leg up could possibly be a measured move of that same extent, as chart shows. At this point I see another potential major rally right around the corner.
- Most importantly, on September 8th, the company announced that its Board of Directors has initiated a review of strategic alternatives for the company focused on maximizing stockholder value.
As i said several times on twitter, I still holding my shares because i do think it could reach the $2 price level or more in the coming sessions. Be sure to get it on your radars. Im long and I have a stop located at 1.24
- My system detected unusual call buying in the Oct/Nov 5 and 7.5 calls respectively last month
- Steady accumulation on charts - All short-term EMAs are now rising.
- The company is trading below cash per share.
- It recently broke a bullish flag higher, so a new leg up could possibly be a measured move of that same extent, as chart shows. At this point I see another potential major rally right around the corner.
- Most importantly, on September 8th, the company announced that its Board of Directors has initiated a review of strategic alternatives for the company focused on maximizing stockholder value.
As i said several times on twitter, I still holding my shares because i do think it could reach the $2 price level or more in the coming sessions. Be sure to get it on your radars. Im long and I have a stop located at 1.24
( click to enlarge )
Adverum Biotechnologies Inc (NASDAQ:ADVM) During mid-Sept, the price broke out of the key resistance line on high volume and back tested the downtrend line Friday on very low volume. The stock already has a robust set of technicals, including a strong accumulation on charts and has a strong cash-position (>$5.9 per share). I believe this stock could stage a strong bounce off this area of support.
( click to enlarge )
I am also eyeing ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) as a potential bounce play next week. We could see a strong bounce off these lows up towards 30 over the next few sessions due to its extreme oversold state.
( click to enlarge )
I detected unusual call volume in DHT Holdings Inc (NYSE:DHT) on Friday. Watch this stock if it breaks next week above the 4.57 price level. It's a short-squeeze candidate.
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: ACAD, ADVM, DHT, IPCI, TKAI
